NL-OMON43241招募中不适用
Coagulation parameters in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis during and after dose reduction of biologicals - Effects of dose reduction of biologicals on coagulation
Jan van Breemen Instituut0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Diagnosis RA, AS or PsA
- •Use of biologicals
- •Reducing biological due to low disease activity (to be determined by the treating rheumatologist)
排除标准
- •Insufficient understanding of the Dutch language to be able to sign informed consent
研究者
相似试验
已完成
不适用
Findings of Rheumascan in patients with rheumatoid arthritis and other arthritis-related diseasesJPRN-UMIN000014037Tokyo Medical and Dental University110
已完成
不适用
Specific coagulation impairment in patients with and without extracorporeal lung support during COVID-19-ARDSJ80.03D68.01DRKS00025519Klinik für Anästhesie und Intensivmedizin Universitätsklinikum Freiburg27
已完成
不适用
Coagulation and fibrinolysis in patients with resistance to thyroid hormone due to a thyroid hormone receptor β-gene mutatioinsensitivity for thyroid hormone because of a change in the DNAthyroid hormone resistance because of a gene mutation100836241004373910014523NL-OMON38471Academisch Medisch Centrum36
招募中
不适用
Assessment of coagulation status in patients undergoing cardiac surgery with cardiopulmonary bypassAdult patients undergoing elective cardiac valve surgery with cardiopulmonary bypassJPRN-UMIN000041097Jichi Medical University, Saitama Medical Center30
已完成
不适用
Clinical outcome in patients with rheumatoid arthritis switched to tumor nesrosis factor blockers after tocilizumab or abataceptrheumatoid arthritisJPRN-UMIN000016950Osaka Medical College50